Gene targeting strategy for B-hCD106 MC38 cells. The exogenous promoter and human VCAM1 coding sequence was inserted to replace part of murine exon 2. The insertion disrupts the endogenous murine Vcam1 gene, resulting in a non-functional transcript.

CD106 expression analysis in B-hCD106 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hCD106 MC38 cultures were stained with species-specific anti-CD106 antibody. Human CD106 was detected on the surface of B-hCD106 MC38 cells but not wild-type MC38 cells. The 7-C02 clone of B-hCD106 MC38 cells was used for in vivo experiments.

Subcutaneous homograft tumor growth of B-hCD106 MC38 cells. B-hCD106 MC38 cells (5x10⁶) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hCD106 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.